Navigation Links
Keryx Biopharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
Date:5/9/2008

Keryx to Host Investor Conference Call on Monday, May 12, 2008 at 8:30am

EDT

NEW YORK, May 9 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including renal disease and cancer, today announced its results for the first quarter ended March 31, 2008.

At March 31, 2008, the Company had cash, cash equivalents, investment securities, interest receivable and license receivable of $47.6 million, as compared to $64.7 million at December 31, 2007. In April 2008, we received a payment of $8.0 million that was classified as a license receivable at March 31, 2008. The payment was made pursuant to the September 2007 licensing agreement among Keryx, Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd.

The net loss for the first quarter ended March 31, 2008 was $34,536,000, or $0.79 per share, compared to a net loss of $21,813,000, or $0.50 per share, for the first quarter in 2007, representing an increase in net loss of $12,723,000. The increase in net loss was primarily attributable to costs associated with the cessation of our development of Sulonex. Such costs included an $11,037,000 non-cash impairment charge related to the write-down of the assets of the Sulonex manufacturing suite to their estimated fair value, and a $2,063,000 provision for estimated costs relating to the required restoration of the manufacturing facility to its original condition, partially offset by a decrease of $2,264,000 in non-cash compensation expense, primarily related to stock options and restricted
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
2. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
3. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
4. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
5. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
6. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
7. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
8. Keryx Biopharmaceuticals Announces Additions to Management Team
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
10. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
11. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...,, PARSIPPANY, N.J., Nov. 5 DSM...as made a manufacturing alliance with Galenix, Sai...ferred commercial scale manufacturing partner for ..., DSM and Galenix will collaborate on business de...delivery technologies, based on the strength of Ga...
(Date:11/5/2009)...,, OMAHA, Neb., Nov. 5 /PRNewswire-FirstCall/ -...day announced financial results for the quarter en...sults are presented in the tables that follow. ,... a net loss of $366,000 or $0.01 per share for the...f $499,000 or $0.01 per share for the third quarte...
(Date:11/5/2009)...,, SAN DIEGO, CA, November 5, 2009 /PRNewswire-...mpany focused on using proprietary taste receptor-...ients for the food, beverage, and ingredient suppl...d reported financial results for the third quarter...lion for the third quarter of 2009, compared to $4...
(Date:11/5/2009)... Drug safety specialty fi... eLearning and Informatics earned the Certified Pr...P) credential from the American Society for Traini... Michelle Flewell has more than fifteen years of ...perience and is responsible for the development of...
Breaking Biology Technology:DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 4
... YORK, May 15 Cadus Corporation (OTC,Bulletin Boa...e first,quarter ended March 31, 2008., Revenues f...ed to,$100,000 for the same period in 2007. Net lo...pared to net loss of $558,469 for the same period ...d to a decrease in general,and administrative expe...
...FORD, Mass., May 15 Hologic, Inc. (Nasdaq:,HOLX) ...fficer, will be,presenting at the Citigroup Invest...eld May 21 - 22, 2008, at the Hilton Hotel in New ...n to a live audio webcast of,Hologic,s investor pr...,Eastern Time on the investor section of the Compa...
... YORK and BARCELONA, Spain, May 15 Forest,Laborat...ll, S.A. (ALM.MC),will host a webcast to discuss a...indings presented at the American Thoracic Society...a slide presentation and a Q&A session,will occur ..., 3:30pm CET,2:30pm UKT., (Logo: http://www.news...
Other Biology Technology:Cadus Reports First Quarter 2008 Results 2Cadus Reports First Quarter 2008 Results 3Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at the American Thoracic Society Annual Congress 2
(Date:11/4/2009)...7 Global Rainmakers, Inc., an inte...mp;D laboratory, today announced that the company ...ctively commercialize its suite of technologies de... offerings. ,, During the past four years, the ...evelop and deploy a series of core--but expandable...
(Date:11/4/2009)... Glencoe Software, Inc., the commer...Consortium ( http://openmicroscopy.org ), is pro... Society of Cell Biology,s exciting new project ti...en awarded a $2.5M stimulus grant through the Nati...ies program, as part of the American Reinvestment ...
(Date:11/3/2009)...be the ultimate loner of the ocean, cruising thous...searchers has discovered that the sharks have main... over tens of thousands of years the white sharks ...hemselves into a population genetically distinct f...ks are a large, highly mobile species," said Salva...
Breaking Biology News(10 mins):Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 4Breakthrough Nanotechnology Delivers Safe Nutrition Packed Cellular Hydration 47888 1Breakthrough Nanotechnology Delivers Safe Nutrition Packed Cellular Hydration 47888 2Breakthrough Nanotechnology Delivers Safe Nutrition Packed Cellular Hydration 47888 3Recovery Audit Contractor Connolly Healthcare Licenses Milliman Care Guidelines 28R 29 47886 1Recovery Audit Contractor Connolly Healthcare Licenses Milliman Care Guidelines 28R 29 47886 2Recovery Audit Contractor Connolly Healthcare Licenses Milliman Care Guidelines 28R 29 47886 3Anpath Group Inc Announces Selection of its Cleaner by the Toronto Transit System 47881 1Anpath Group Inc Announces Selection of its Cleaner by the Toronto Transit System 47881 2
...rvivors might have a patch of laboratory-grown mus...ied during their attack. Children born with defect...in place, rather than being replaced every few yea...might get a new “natural?replacement, instead of a...ithin reach, and could transform the way heart car...
...published in the latest issue of The Journal of Se...sychology of McGill University, thermography shows... sexual arousal. It is less intrusive than current...t that requires no physical contact with participa...t can be used to diagnose sexual health problems i...
...d flu, involving the use of a mathematical model, ...tiviral drugs might be the best way to deal with a...enza) has not triggered a worldwide human epidemic...t does acquire this ability, it would take 6-8 mon... virus. Public health officials therefore need to ...
Other Biology News:Engineering the heart piece by piece 2Engineering the heart piece by piece 3Engineering the heart piece by piece 4New measure of sexual arousal found for both men and women 2
...Linear Ion Trap Time of Flight Mass Analyzer for s...power., Specifications:, * MS mode measurement r...range: 150 - 4000 m/z, * Resolution: 14,000 (1400 ...eference, * Dynamic range: 4 orders of magnitude ...
...lay Vector is specifically designed to target and ...charomyces cerevisiae. Displayed proteins can be a...r putative ligands. pYD1 uses the a-agglutinin yea..., Aga1 and Aga2, to display recombinant protein on...
...is a pleiotropic cytokine produced by activated T ...nhibits the growth of some tumour and normal cell ...osis sarcoma cell proliferation, cytokine release ... receptor expression on hepatoma cells. Mouse OSM ...
Mouse Anti-Human BTAF1 Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products: